Results
Emcure FY26 Revenue Crosses $1 Billion, Grows 16.6%
Emcure Pharmaceuticals reported audited FY26 results, exceeding revenue guidance with 16.6% growth to cross the US$1 billion milestone.
International business was the key growth driver, up 22% YoY and
